The sequential change of serum concentrations of iron metabolic markers after administration of erythropoiesis stimulating agent in HD Patients
Not Applicable
Completed
- Conditions
- HD Patients
- Registration Number
- JPRN-jRCT1090220198
- Lead Sponsor
- Shigeru Miyazaki
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 28
Inclusion Criteria
HD Patients without administration of erythropoesis stimulating agenst
Exclusion Criteria
Malignant disease, Liver cirrhosis, Heart failure
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method change of serum concentration of iron metabolic markers after administration of erythropoiesis stimulating agent
- Secondary Outcome Measures
Name Time Method